Hepatitis B Reactivation and Antiviral Prophylaxis in Patients on Immunosuppressive Therapy

Objectives: Hepatitis B virus reactivation (HBVr) may occur in patients receiving immunosuppressive therapy. The risk of HBVr varies depending on the immunosuppressive agent used and hepatitis serology. This study aimed to evaluate HBVr among immunosuppressed patients with and without antiviral prop...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yakup Gezer, Arzu Tarakçı
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Galenos Publishing House 2025-12-01
Edice:	Viral Hepatitis Journal
Témata:	anti-hbc-positive antiviral prophylaxis corticosteroids hbsag positive immunosuppressive therapy rituximab
On-line přístup:	https://viralhepatitisjournal.org/articles/hepatitis-b-reactivation-and-antiviral-prophylaxis-in-patients-on-immunosuppressive-therapy/doi/vhd.galenos.2026.2025-10-1
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!